CJLM Meijer

3.0k citations

16 papers · 2.3k indexed · 2 hit papers · h-index 15

Epidemiology top 1%
- Cervical Cancer and HPV Research 11
- Hepatitis B Virus Studies 2
Microbiology top 1%
- Reproductive tract infections research 3
Obstetrics and Gynecology top 5%
Surgery top 5%
- Genital Health and Disease 3
Oncology top 5%
- Global Cancer Incidence and Screening 2
Immunology
- Immunotherapy and Immune Responses 3
- T-cell and Retrovirus Studies 2
Artificial Intelligence
- AI in cancer detection 2

Co-authors: PJF Snijders Johannes Berkhof Marjolein van Ballegooijen RHM Verheijen Folkert J. van Kemenade Rolando Herrero Salvatore Vaccarella Silvano Gallus
Cited by: Epidemiology Microbiology Obstetrics and Gynecology
Partner nations: Netherlands France Greece

In The Last Decade

CJLM Meijer

16 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2007 Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
2005 Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

Peers

Countries citing papers authored by CJLM Meijer

Since Specialization

Citations

This map shows the geographic impact of CJLM Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CJLM Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CJLM Meijer more than expected).

Fields of papers citing papers by CJLM Meijer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CJLM Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CJLM Meijer. The network helps show where CJLM Meijer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside CJLM Meijer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with CJLM Meijer Line = papers co-authored together CJLM Meijer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review WW Kremer,Renske D.M. Steenbergen,DAM Heideman,GG Kenter,CJLM Meijer	2020	69
2	Agreement between colposcopic impression and histological diagnosis among human papillomavirus type 16‐positive women: a clinical trial using dynamic spectral imaging colposcopy Afra Zaal,J.A. Louwers,Johannes Berkhof,Mariëlle Kocken,WA ter Harmsel,GCM Graziosi,JWM Spruijt,Costas Balas,Emmanouil Papagiannakis,PJF Snijders,CJLM Meijer,Folkert J. van Kemenade,RHM Verheijen	2012	42
3	Effector memory T‐cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients A.W. Turksma,Hetty J. Bontkes,H. van den Heuvel,TD de Gruijl,BME von Blomberg,BJM Braakhuis,C. René Leemans,Elisabeth Bloemena,CJLM Meijer,Erik Hooijberg	2012	32
4	Dynamic spectral imaging colposcopy: higher sensitivity for detection of premalignant cervical lesions J.A. Louwers,Afra Zaal,Mariëlle Kocken,WA ter Harmsel,GCM Graziosi,JWM Spruijt,Johannes Berkhof,Costas Balas,Emmanouil Papagiannakis,PJF Snijders,CJLM Meijer,Folkert J. van Kemenade,RHM Verheijen	2010	63
5	Vaccination against HPV: indications for women and the impact on the cervical screening programme DAM Heideman,PJF Snijders,Johannes Berkhof,R. Verheijen,TJM Helmerhorst,CJLM Meijer	2008	16
6	Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialbreakdown → NWJ Bulkmans,Johannes Berkhof,Lawrence Rozendaal,Folkert J. van Kemenade,A. J. P. Boeke,Saskia Bulk,FJ Voorhorst,RHM Verheijen,K. van Groningen,M. E. Boon,W Ruitinga,Marjolein van Ballegooijen,PJF Snijders,CJLM Meijer	2007	483
7	Immunohistochemical profiling based on Bcl‐2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma JJF Muris,CJLM Meijer,W Vos,JHJM van Krieken,NM Jiwa,G.J. Ossenkoppele,JJ Oudejans	2006	179
8	Churn Prediction in the Mobile Telecommunications Industry R. Braekers,CJLM Meijer	2006	7
9	Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysisbreakdown → Gm Clifford,Silvano Gallus,Rolando Herrero,Núbia Muñóz,PJF Snijders,Salvatore Vaccarella,PTH Anh,Catterina Ferreccio,N. T. Hieu,Elena Matos,Mónica Molano,Rajamanickam Rajkumar,Guglielmo Ronco,Sílvia de Sanjosé,H. R. Shin,Sukhon Sukvirach,JO Thomas,Sirirat Tunsakul,CJLM Meijer,Silvia Franceschi	2005	828
10	Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and -negative anal carcinoma Morten Frisch,Bengt Glimelius,AJC van den Brule,Jan Wohlfahrt,CJLM Meijer,JMM Walboomers,H‐O Adami,Mads Melbye	1998	33
11	Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells JJ Bijl,JW van Oostveen,JMM Walboomers,ATP Brink,W Vos,GJ Ossenkoppele,CJLM Meijer	1998	14
12	Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness Marjolein van Ballegooijen,M. Elske van den Akker‐van Marle,PG Warmerdam,CJLM Meijer,JMM Walboomers,JDF Habbema	1997	65
13	Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction A-M. de Roda Husman,PJF Snijders,HV Stel,AJC van den Brule,CJLM Meijer,JMM Walboomers	1995	120
14	Human papillomavirus and invasive cervical cancer in Brazil José Eluf‐Neto,Margaret Booth,N Muñoz,F. Xavier Bosch,CJLM Meijer,JMM Walboomers	1994	209
15	Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions FV Cromme,CJLM Meijer,PJ Snijders,Anne M. Uyterlinde,Peter Kenemans,Th.J.M. Helmerhorst,PL Stern,AJC van den Brule,JMM Walboomers	1993	105
16	Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48 IgG Martijn Gerretsen,AHGJ Schrijvers,Marijke van Walsum,BJM Braakhuis,Jasper J. Quak,CJLM Meijer,G. B. Snow,GAMS van Dongen	1992	19

About CJLM Meijer

CJLM Meijer is a scholar working on Microbiology, Epidemiology and Immunology, having authored 16 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (11 papers), Immunotherapy and Immune Responses (3 papers), Reproductive tract infections research (3 papers), Genital Health and Disease (3 papers), T-cell and Retrovirus Studies (2 papers), Global Cancer Incidence and Screening (2 papers), AI in cancer detection (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Epidemiology (1.8k citations), Microbiology (325 citations) and Obstetrics and Gynecology (159 citations). CJLM Meijer has collaborated with scholars based in Netherlands, France and Greece. Frequent co-authors include PJF Snijders, Johannes Berkhof, Marjolein van Ballegooijen, RHM Verheijen, Folkert J. van Kemenade, Rolando Herrero, Salvatore Vaccarella, Silvano Gallus, Mónica Molano and Guglielmo Ronco.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact